A Headache for Cardiologists: Ischemia with Non-Obstructive Disease

Treating patients with functional stress test induced ischemia and non-obstructive coronary artery disease (INOCA) is complex and often frustrating. 

Isquemia con enfermedad NO obstructiva.

The multifactorial nature of this disease in addition to the complex physiopathological relationship between angina and ischemia turn these patients into a real headache for cardiologists.

The CIAO-ISCHEMIA was recently published in Circulation and was designed to describe the natural history of symptoms and ischemia in patients with INOCA.

Patients included in this study are peculiar because they had been excluded from ISCHEMIA randomization for failing to meet the criteria for obstructive coronary artery disease.

They all presented angina and stress-induced wall motion abnormalities. The echocardiographic core laboratory was blinded to symptoms, coronary and the presence of coronary artery disease (CAD). 

The pharmacological treatment was left to physician criteria. Primary end point was the correlation between changes in angina frequency and changes in stress echocardiogram. Predictors were analyzed at one year after changes in symptoms and ischemia. These patients were also compared against those included in the ISCHEMIA trial (the only difference being the presence of obstructive CAD).


Read also: Post COVID-19 Persistent Symptoms: Far More Common than Expected.


Patients with INOCA included in the CIAO were far more often women (66% vs 26%) vs ISCHEMIA patients with obstructive CAD (p<0.001). Despite the latter, ischemia magnitude resulted similar between cohorts (median 4 ischemic segments).

Ischemia and angina symptoms were not correlated in CIAO or ISCHEMIA.

After one year, stress echocardiogram resulted normal in half the CIAO participants, while a quarter continued with severe to moderate stress induced ischemia (≥3 ischemic segments). Angina improved in nearly half of patients (43%) though not necessarily the same who saw improved ischemia. In fact, there was no correlation. 


Read also: AAS vs DAPT post TAVI: Meta-Analysis of Randomized Studies.


These are the inconsistencies between stress symptoms and signs that make INOCA patients so challenging when it comes to treating them.  

Conclusion

Treatment improved ischemia and angina in INOCA patients, even though there was no correlation between both. Stress induced ischemia amounts resulted similar between the CIAO cohort (with no obstructive lesions) and the ISCHEMIA cohort (with obstructive CAD). 

Original Title: Natural History of Patients with Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.

Reference: Harmony R. Reynolds et al. Circulation. 2021 Jun 1. Online ahead of print. doi: 10.1161/CIRCULATIONAHA.120.046791. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...